{{Rsnum
|rsid=2121875
|Gene=FGF10
|Chromosome=5
|position=44365443
|Orientation=minus
|GMAF=0.4826
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=FGF10
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 8.8 | 52.2 | 38.9
| HCB | 30.7 | 44.5 | 24.8
| JPT | 22.1 | 52.2 | 25.7
| YRI | 65.3 | 31.3 | 3.4
| ASW | 33.3 | 56.1 | 10.5
| CHB | 30.7 | 44.5 | 24.8
| CHD | 33.0 | 50.5 | 16.5
| GIH | 14.9 | 47.5 | 37.6
| LWK | 65.5 | 31.8 | 2.7
| MEX | 29.3 | 58.6 | 12.1
| MKK | 48.1 | 41.7 | 10.3
| TSI | 12.9 | 42.6 | 44.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21743467
|Trait=None
|Title=Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|RiskAllele=G
|Pval=4E-8
|OR=1.0500
|ORtxt=[1.02-1.08]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}